Clinical Trials Directory

Trials / Terminated

TerminatedNCT00428571

Laparoscopic Bariatric Surgery to Treat Type 2 Diabetes in Obese Patients

Laparoscopic Bariatric Surgery for Treatment of Type 2 Diabetes in Obese Patients With End Organ Damage: A Prospective Randomized Controlled Pilot Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Hamilton Health Sciences Corporation · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

A large number of research studies on people who were morbidly obese (extremely overweight), and had bariatric surgery (anti-obesity surgery) have shown that patients who were diabetic before surgery often experienced significant improvement in their diabetes following the surgery. For some patients, blood glucose levels returned to the normal range, and they were able to stop taking all of their diabetes medications. For others, blood glucose levels improved, allowing them to reduce their diabetes medications. This research study is being done to determine whether bariatric surgery can safely provide better control of diabetes symptoms in obese diabetics than continuing medical management (anti-diabetic drugs in combination with diet and lifestyle changes). There are several different types of bariatric surgery currently being used to treat morbid obesity. Two of the most common techniques are gastric bypass and adjustable gastric banding. This study will be comparing these two surgical techniques to treatment with a combination of drugs, diet, and lifestyle changes for control of type 2 diabetes.

Conditions

Interventions

TypeNameDescription
PROCEDURElaparoscopic gastric bypass surgeryLaparoscopic Gastric Bypass Surgery
PROCEDURElaparoscopic adjustable gastric bandinglaparoscopic adjustable gastric banding
PROCEDUREIntensive Medical Managementlifestyle, diet, medication optimization

Timeline

Start date
2007-05-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2007-01-30
Last updated
2016-04-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00428571. Inclusion in this directory is not an endorsement.